跳至主要内容
临床试验/RBR-6pqx4n
RBR-6pqx4n进行中(未招募)未知

Efficacy of Duloxetine in Chronic temporomandibular disorder: a randomized clinical trial

Faculdade de Odontologia de Bauru0 个研究点开始时间: 2018年9月3日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 60Y(—)

入选标准

  • age greater than 18 years, diagnosis of painful TMD, for example, masticatory myalgia, arthralgia of the temporomandibular joint and headache attributed to TMD diagnosed according to Diagnostic Criteria for Temporomandibular Disorder; presence of pain for at least 3 months

排除标准

  • presence of uncontrolled systemic disorders, for example, diabetes, hypertension or endocrine disorders; presence of epilepsy, renal, hepatic and cardiac disorders; presence of neuropathies; pregnancy or lactation; intolerance to duloxetine or any component of the formulation; treatment for TMD in the last 3 months

研究者

发起方
Faculdade de Odontologia de Bauru

相似试验